DESTROY DUCHENNE
EIN 82-3268952 · Fund Raising & Fund Distribution - Medical Research (H12)
What they do
WITH THE DEVELOPMENT and RISE of GENE EDITING, CRISPR-CAS9, TECHNOLOGIES, HUMANITY HAS A REAL OPPORTUNITY to CURE VIRTUALLY ALL GENETIC DISEASES, SUCH AS DUCHENNE MUSCULAR DYSTROPHY. GENE EDITING TECHNOLOGY HAS GIVEN US THE ABILITY to REWRITE OUR DNA and CORRECT FAULTY DNA, LIKE MUTATIONS THAT CAUSE DISEASES. THE APPLICATIONS for GENE EDITING to IMPROVE THE WORLD ARE NEARLY ENDLESS and WE WANT to BE THE CHAMPION of ADVANCING GENE EDITING to HUMAN TRIALS for PEOPLE WITH DUCHENNE. IT COULD BE SAID THAT THE CURRENT STATE of GENE EDITING TECHNOLOGY, CRISPR-CAS9, is THE TOOL to CURE DUCHENNE THAT NEEDS to BE PERFECTED BEFORE IT CAN BE APPLIED IN HUMANS. MORE SCIENTIFIC STUDIES NEED to BE DONE to PERFECT THIS TOOL, CRISPR-CAS9, and THAT is WHY WE SO PASSIONATELY SAY WE NEED TO: COMPLETE THE CURE.
Financial picture
About this charity
- Recognized since
- January 2018
- Location
- 3182 VANDERMOLEN DR, NORCO, CA 92860-5148
- County
- Riverside
- In care of
- % KELLY DIANN STACY
- Primary officer
- DAN LANG, TREASURER
How to reach them
Filing and classification
- Latest tax year
- 2025
- Tax period began
- January 1, 2021
- Return type
- 990EZ
- Tax preparer
- SACKETT FINANCIAL GROUP
- NTEE classification
- Fund Raising & Fund Distribution - Medical Research (H12)
- IRS tax category
- Fund Raising & Fund Distribution
More public IRS record details
These are classification codes from the organization’s public nonprofit record.
- Subsection
- 03
- Affiliation
- 3
- Classification
- 1200
- Deductibility
- 1
- Foundation
- 15
- Organization
- 1